- Home
- NBTX vs TBLA Comparison
NBTX vs TBLA Comparison
Compare NBTX & TBLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- TBLA
- Stock Information
- Founded
- NBTX 2003
- TBLA 2007
- Country
- NBTX France
- TBLA United States
- Employees
- NBTX N/A
- TBLA 2000
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- TBLA Computer Software: Programming Data Processing
- Sector
- NBTX Health Care
- TBLA Technology
- Exchange
- NBTX Nasdaq
- TBLA Nasdaq
- Market Cap
- NBTX 868.8M
- TBLA 976.2M
- IPO Year
- NBTX 2020
- TBLA N/A
- Fundamental
- Price
- NBTX $21.04
- TBLA $3.21
- Analyst Decision
- NBTX Strong Buy
- TBLA Strong Buy
- Analyst Count
- NBTX 1
- TBLA 5
- Target Price
- NBTX $8.00
- TBLA $4.50
- AVG Volume (30 Days)
- NBTX 112.7K
- TBLA 1.1M
- Earning Date
- NBTX 09-30-2025
- TBLA 11-06-2025
- Dividend Yield
- NBTX N/A
- TBLA N/A
- EPS Growth
- NBTX N/A
- TBLA N/A
- EPS
- NBTX N/A
- TBLA 0.04
- Revenue
- NBTX $11,930,711.00
- TBLA $1,817,019,000.00
- Revenue This Year
- NBTX N/A
- TBLA $8.37
- Revenue Next Year
- NBTX $74.67
- TBLA $4.65
- P/E Ratio
- NBTX N/A
- TBLA $81.12
- Revenue Growth
- NBTX N/A
- TBLA 12.01
- 52 Week Low
- NBTX $2.76
- TBLA $2.50
- 52 Week High
- NBTX $22.51
- TBLA $4.30
- Technical
- Relative Strength Index (RSI)
- NBTX 71.69
- TBLA 32.35
- Support Level
- NBTX $19.11
- TBLA $3.28
- Resistance Level
- NBTX $22.64
- TBLA $3.60
- Average True Range (ATR)
- NBTX 1.64
- TBLA 0.08
- MACD
- NBTX 0.63
- TBLA -0.03
- Stochastic Oscillator
- NBTX 83.03
- TBLA 2.47
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About TBLA Taboola.com Ltd.
Taboola.com Ltd is a technology company that powers recommendations across the Open Web with an artificial intelligence-based, algorithmic engine. It partners with websites, devices, and mobile apps, collectively referred to as digital properties, to recommend editorial content and advertisements on the Open Web. Geographically it serves Israel, the United Kingdom, United States, Germany, Rest of the world. It generates the majority of its revenue from the United States.